EU waives Takeda/Shire merger commitments
The European Commission has waived the conditions it imposed on Takeda’s 2018 takeover of rival Shire due to “permanent, significant and unforeseeable developments” that occurred as the drugmaker attempted to complete its required divestiture.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.